These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2855625)

  • 1. The effect of sodium valproate on plasma ACTH and cortisol concentrations in Cushing's disease and Nelson's syndrome.
    Kasperlik-Załuska A; Drac-Kaniewska J; Migdalska B; Jeske W; Wiśniewska-Woźniak T
    Endokrynol Pol; 1988; 39(5):245-52. PubMed ID: 2855625
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
    Reincke M; Allolio B; Kaulen D; Jaursch-Hancke C; Winkelmann W
    Klin Wochenschr; 1988 Aug; 66(15):686-9. PubMed ID: 2845188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
    Loli P; Berselli ME; Frascatani F; Muratori F; Tagliaferri M
    J Endocrinol Invest; 1984 Apr; 7(2):93-6. PubMed ID: 6327800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlative study between cortisol and ACTH in Cushing's disease following bilateral adrenalectomy and in Nelson's syndrome.
    Kasperlik-Załuska A; Niegowska E; Migdalska B; Jeske W; Zieliński M
    Endokrynol Pol; 1992; 43(3):314-21. PubMed ID: 1345571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome.
    Kasperlik-Załuska AA; Zgliczyński W; Jeske W; Zdunowski P
    Neuro Endocrinol Lett; 2005 Dec; 26(6):709-12. PubMed ID: 16380696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of Nelson's syndrome with sodium valproate.
    Kelly W; Adams JE; Laing I; Longson D; Davies D
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):195-204. PubMed ID: 2844446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.
    Ambrosi B; Bochicchio D; Riva E; Faglia G
    J Endocrinol Invest; 1983 Aug; 6(4):305-6. PubMed ID: 6315806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease.
    Elias AN; Gwinup G; Valenta LJ
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):151-4. PubMed ID: 6273025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.
    Lamberts SW; Uitterlinden P; Klijn JM
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):760-6. PubMed ID: 2543178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of sodium valproate in the treatment of Nelson's syndrome.
    Dornhorst A; Jenkins JS; Lamberts SW; Abraham RR; Wynn V; Beckford U; Gillham B; Jones MT
    J Clin Endocrinol Metab; 1983 May; 56(5):985-91. PubMed ID: 6300181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary.
    Koppeschaar HP; Croughs RJ; van't Verlaat JW; Hendriks MJ; Arts CJ; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):471-5. PubMed ID: 6097074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome.
    Lamberts SW; Klijn JG; de Quijada M; Timmermans HA; Uitterlinden P; de Jong FH; Birkenhäger JC
    J Clin Endocrinol Metab; 1980 Aug; 51(2):307-11. PubMed ID: 6249835
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?].
    Horký K; Kanka J; Gregorová I; Tomsová Z; Dvoráková J
    Cas Lek Cesk; 1990 May; 129(21):645-9. PubMed ID: 2164450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome.
    Kasperlik-Zaluska AA; Jeske W
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):351-5. PubMed ID: 6246703
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of treatment with sodium valproate and diazepam on plasma corticotropin in Nelson's syndrome.
    Jones MT; Gillham B; Beckford U; Dornhorst A; Abraham RR; Seed M; Wynn V
    Lancet; 1981 May; 1(8231):1179-8. PubMed ID: 6112528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unaltered stimulation of pituitary adrenocorticotrophin secretion by corticotrophin-releasing factor following sodium valproate administration in a patient with Nelson's syndrome.
    Gomi M; Iida S; Itoh Y; Moriwaki K; Kanayama S; Namba M; Tarui S
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):123-7. PubMed ID: 2996808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.